Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
MEI Pharma, Inc. (MEIP) had Free Cash Flow per Share of $-2.76 for the most recently reported fiscal quarter, ending 2025-03-31.
Income Statement Financials | |
-- |
|
$-2.57M |
|
-- |
|
-- |
|
$2.77M |
|
$-2.77M |
|
$0.20M |
|
$-2.57M |
|
$-2.57M |
|
$-2.57M |
|
$-2.57M |
|
$-2.57M |
|
$-2.57M |
|
$-2.77M |
|
$-2.77M |
|
6.66M |
|
6.66M |
|
$-0.39 |
|
$-0.39 |
|
Balance Sheet Financials | |
$20.78M |
|
-- |
|
-- |
|
$20.78M |
|
$1.24M |
|
-- |
|
-- |
|
$1.24M |
|
$19.54M |
|
$19.54M |
|
$19.54M |
|
6.66M |
|
Cash Flow Statement Financials | |
$-18.38M |
|
$35.15M |
|
-- |
|
$3.71M |
|
$20.47M |
|
$16.77M |
|
$-0.22M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
16.78 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-18.37M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-13.17% |
|
-13.17% |
|
-12.38% |
|
-13.17% |
|
$2.93 |
|
Free Cash Flow per Share |
$-2.76 |
$-2.76 |